Dr. Armando E. Giuliano has a minimally invasive approach toward breast cancer treatment, and thanks to philantropic support, his investigations could serve as the foundation for earlier detection and increasingly targeted treatment.
Cedars-Sinai investigators partner around the globe to export the medical center’s lifesaving advances in biomedicine to physicians and patients in need.
Asparagine, a nonessential amino acid commonly found in food, may hold a key to limiting the spread of an often-deadly type of breast cancer.
While air pollution has long been linked to disease, a recent Cedars-Sinai study reveals how nickel particles and other airborne matter influence genetics in a potentially damaging way.
Imaging Technology Takes Aim at Aggressive Tumors Prostate cancer affects 1 in 9 U.S. men. Now, breakthrough imaging technology will allow physicians to zap such tumors with unprecedented accuracy. Cedars-Sinai researchers are testing a system that combines two kinds of Read On
After years of failure, immunotherapy finally is working wonders for some cancers, transforming death sentences into long-term remission. The problem? It doesn’t work in most cancers — at least, not yet.
An experimental device snags tumor cells like Velcro to speed cancer diagnosis and predict disease spread. The experimental device, the NanoVelcro Chip, could replace traditional biopsies with a simple blood draw.
A study shows how cigarettes may cause pancreatic cancer — and uncovers a potential way to treat it.